Prospective validation of ORACLE, a clonal expression biomarker associated with survival of patients with lung adenocarcinoma – Nature Cancer vm_adminJanuary 14, 2025 Cancer Research UK Lung Cancer Centre of Excellence, University College London Cancer Institute, London, UKDhruva Biswas, Yun-Hsin Liu, David A. Moore, Takahiro Karasaki, Kristiana Grigoriadis, Selvaraju Veeriah, Cristina Naceur-Lombardelli, Neil Magno, Sophia Ward, Alexander M. Frankell, Ariana Huebner, Corentin Richard, Crispin T. Hiley, Emilia L. Lim, Francisco Gimeno-Valiente, Krupa Thakkar, Maise Al Bakir, Monica Sivakumar, Ieva Usaite, Sadegh Saghafinia, Sharon…Article Source https://www.nature.com/articles/s43018-024-00883-1 Facebook Twitter Pinterest LinkedIn Digg Tumblr Reddit Buffer Blogger Newsvine HackerNews Flipboard Share LiveJournal Yammer Mix Instapaper Copy Link Mastodon
Oracle (ORCL) reports quarterly results on MondayBy @MarketBeatCom Publication Date: 2025-12-01 06:22:00 Oracle (NYSE:ORCL) will report its second quarter 2026 earnings results before the market opens…
Oracle: The AI infrastructure giant is hiding in plain sightBy Steven Fiorillo Publication Date: 2026-03-13 12:30:00 Oracle’s third-quarter surge shows AI-driven cloud growth, record RPO and a contrarian ORCL…
The Rise of US Customer Data Platform Market: A $6.4 billion Industry Dominated by Oracle Corporation, Adobe & Salesforce | MarketsandMarkets™Delray Beach, FL, April 04, 2025 (GLOBE NEWSWIRE) — The US Customer Data Platform Market is expected to reach USD…